#full disclaimer none of this infos provided out of ill-will

[keykite]

do you have any archived info about rtcd? like any info about the characters, art done, potential plot ect?

hey anon! at this moment i dont (sadly i didnt get around to archiving all of the spotify playlists before they were taken down) but i do remember some info. the main character (i dont remember his name) was a lesbian that used he/him and cat/catself i believe ... and kitsune's ex was going to be an antagonist? the one who took advantage of them prior to wtcd i believe. there was a genderfae character and a hijabi who needed hearing aids/was deaf i believe. also i think ntombi's sibling wouldve been in it. i do believe ... actually. hang on. we do have a cast list and at one point we HAD icons ..... ahhhhgh. okay i'm gonna draft this for now and come back after i do some digging..

okay! im back from my adventure! i found the spotify playlists.

and let me copy out the cast list for you, anon. incase you missed it;

delilah zielinski, ultimate librarian, genderfae, she/they

sekai ndlovu, ultimate racecar driver, she/her, aromantic

farah ali, ultimate mini golfer, she/her, lesbian

rin takeda, ultimate game show host, he/zi/they, (presumably) mlm, kitsune's ex

anne-marie viverette, ultimate arsonist, he/cat, lesbian(? if my memory serves), would have been the protagonist

amari adeyemi, ultimate ornithologist, they/them, aromantic (and presumably under the nonbinary umbrella), ntombi's sibling

anah elbaum, ultimate paranormal investigator, she/fae/they, lesbian

garmal ahmad, ultimate lifeguard, he/him, bisexual

katsumi fukei, ultimate performer, she/her, (presumably) wlw

akemi masashi, ultimate prince, he/him (no recorded image of his design or flags)

hayato fujioka, ultimate barista, he/they/fae (no recorded images of their design or flags)

sumiko takahashi, ultimate sailor, he/him (no recorded images of his design or flags)

meiko kutsuki, ultimate poet, they/them (no recorded images of their design or flags)

yuko kamiya, ultimate exorcist, he/it (no recorded images of its design or flags, but it had a playlist at one point)

yoichi sasaki, ultimate escape artist, any except for she/her (no recorded images of xeir design or flags)

aiko hamasaki, ultimate matchmaker, he/him (no recorded images of his design or flags)

also one plot point i totally forgot that was teased, but i was VERY upset about for a good while - angel (main character) and katsumi (akihiro's girlfriend) were implied to be a ship that was going to be canon in wtcd2. for obvious reasons .... this really isnt a good thing. i'm just gonna let my past self explain this one -

sorry this answer got a bit long anon!

[bharatiyamedia-blog]

Researchers establish traits linked to raised outcomes in HPV-linked head and neck most cancers

http://tinyurl.com/yxsa3yvx Utilizing a brand new blood take a look at that is in improvement, College of North Carolina Lineberger Complete Most cancers Heart researchers recognized traits that might be used to personalize remedy for sufferers with a sort of head and neck most cancers linked to HPV an infection. Researchers consider the findings, revealed within the journal Medical Most cancers Analysis, might assist establish these sufferers with traits linked to improved remedy responses. They hope to tailor remedy for these sufferers to scale back their publicity to potential poisonous unwanted effects. “Head and neck cancers which might be brought on by HPV an infection are inclined to have a greater total consequence than head and neck cancers associated to different elements like smoking and alcohol,” stated UNC Lineberger’s Gaorav Gupta, MD, PhD, assistant professor within the UNC College of Medication Division of Radiation Oncology. “There’s been a whole lot of curiosity in exploring whether or not we can provide much less remedy to those sufferers and nonetheless obtain the identical stage of treatment, whereas decreasing the toxicities of remedy. The aim of this research was to analyze whether or not a blood take a look at for circulating tumor HPV DNA can doubtlessly be used to observe the response of a affected person’s most cancers to chemotherapy and radiation.” The researchers developed the take a look at to detect ranges of DNA within the blood from HPV-linked oropharyngeal squamous cell carcinoma tumors. Research are ongoing to see if the take a look at can be utilized to observe sufferers’ response to remedy with radiation and chemotherapy. As well as, the take a look at has been licensed for business improvement to the corporate Naveris Inc. Of their newest work, researchers recognized traits in sufferers that might be used to stratify and personalize remedy. They drew their findings from a research of the blood take a look at outcomes from 103 sufferers who have been present process chemotherapy and radiation for HPV-linked oropharyngeal squamous cell carcinoma. “What this implies is that sooner or later, dynamic, real-time monitoring of circulating tumor HPV DNA within the blood throughout remedy might assist us higher personalize and choose remedy – particularly the extent of radiation and chemotherapy we give the affected person,” stated the research’s first writer, UNC Lineberger’s Bhishamjit S. Chera, MD, affiliate professor within the UNC College of Medication Division of Radiation Oncology. One attribute that emerged from their research as a biomarker of consequence was a excessive stage of circulating tumor HPV DNA within the blood earlier than remedy. For the reason that discovering appears counterintuitive, researchers plan to analyze why a excessive stage of preliminary viral DNA within the blood can be linked to a greater consequence. “It could appear complicated at first, however we expect it displays how addicted the tumor is to HPV biology,” Gupta stated of the discovering. As well as, they discovered that sufferers who then quickly cleared the circulating tumor DNA from their blood have been extra prone to have improved outcomes. Sufferers who have been capable of clear greater than 95 p.c of the DNA from their blood by day 28 of remedy have been thought-about to have a good clearance fee. For 19 out of 67 sufferers with these two favorable biomarkers, they discovered that none had persistent or recurrent illness. “After we put these two elements collectively, which means if somebody had a whole lot of HPV DNA and it cleared rapidly, we did not observe any failures of remedy in our cohort,” Gupta stated. Conversely, they discovered that cancers with low ranges of circulating DNA from tumors on the outset — or lower than 200 copies of HPV DNA per milliliter — and with unfavorable clearance of HPV DNA after remedy had a better threat of recurrence. That threat was even worse when mixed with different threat elements comparable to an in depth historical past of smoking. Researchers at UNC Lineberger are planning to open a scientific trial wherein sufferers are stratified to obtain totally different ranges of remedy based mostly on real-time monitoring of circulating tumor HPV DNA. The deliberate trial, which will probably be led by Colette Shen, MD, assistant professor within the UNC College of Medication Division of Radiation Oncology, will embody sufferers with a smoking historical past and who’re presently not eligible for diminished depth remedy. Through the use of circulating tumor HPV DNA monitoring throughout remedy, the investigators hope to establish sufferers who could also be safely spared the extra toxicities of full depth remedy. ### Along with Chera and Gupta, different authors embody Sunil Kumar, Brian T. Beaty, David Marron, Stuart R. Jeffreys, Rebecca L. Inexperienced, Emily C. Goldman, Robert Amdur, Nathan Sheets, Roi Dagan, D. Neil Hayes, Jared Weiss, Juneko E. Grilley-Olson, Adam M. Zanation, Trevor G. Hackman, Jeffrey M. Blumberg, Samip Patel, Mark Christian Weissler, Xianming Tan, Joel S. Parker, and William M. Mendenhall. Battle of curiosity: Chera and Gupta have fairness curiosity in Naveris, and are each members of the scientific advisory board. They’ve additionally filed a patent utility associated to the take a look at. Funding: The research was supported by the College Most cancers Analysis Fund, the UNC College of Medication Division of Radiation Oncology, UNC Lineberger, and the College of Florida College of Medication Division of Radiation Oncology. Disclaimer: AAAS and EurekAlert! usually are not answerable for the accuracy of reports releases posted to EurekAlert! by contributing establishments or for the usage of any info by the EurekAlert system. Source link